CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report)’s share price shot up 2.8% during trading on Thursday after Citigroup raised their price target on the stock from $88.00 to $89.00. Citigroup currently has a buy rating on the stock. CRISPR Therapeutics traded as high as $57.19 and last traded at $57.11. 273,490 shares were traded […]
Harbor Investment Advisory LLC lessened its holdings in shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 6.8% during the fourth quarter, HoldingsChannel reports. The fund owned 6,170 shares of the company’s stock after selling 450 shares during the period. Harbor Investment Advisory LLC’s holdings in CRISPR Therapeutics were worth $386,000 at the end […]
CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report)’s stock price dropped 5.4% during mid-day trading on Wednesday . The company traded as low as $60.31 and last traded at $61.69. Approximately 842,038 shares changed hands during trading, a decline of 55% from the average daily volume of 1,875,040 shares. The stock had previously closed at […]
SteelPeak Wealth LLC trimmed its position in shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 22.7% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 4,469 shares of the company’s stock after selling 1,311 shares during the quarter. SteelPeak […]
Shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) shot up 3.3% on Thursday . The stock traded as high as $67.20 and last traded at $66.75. 377,631 shares were traded during mid-day trading, a decline of 80% from the average session volume of 1,903,866 shares. The stock had previously closed at $64.60. Wall […]